ADIPOQ and fatty liver disease: Adiponectin levels were significantly lower in the low- and high-grade liver steatosis groups than in the healthy controls (median [IQR], 2.86 [1.93–5.92] μg/mL vs. 6.15 [2.75–9.22] μg/mL, P = 0.036; and 2.81 [1.98–3.72] μg/mL vs. 6.15 [2.75–9.22] μg/mL, P < 0.001, respectively) (Figure 1B).